Literature DB >> 24400597

The influence of hormonal replacement and growth hormone treatment on the lipids in Turner syndrome.

Tomasz Jerzy Irzyniec1, Wacław Jeż.   

Abstract

AIM: Women with Turner syndrome (TS) have a risk of developing cardiovascular diseases. We assessed the lipid and carbohydrate metabolism in TS-women in the context of current hormone replacement therapy (HRT) and growth hormone (GH) treatment during childhood.
METHODS: The information were collected from medical documentation and anamnesis of 165 TS-women (24.9 ± 7.7 yr) between 1995 and 2011. The patients underwent a pituitary-gonadal axis assessment together with measurements of total cholesterol (TC), high- (HDL) and low- (LDL) density lipoproteins, triglycerides (TG), and glucose levels.
RESULTS: Only 58% of women were using HRT. No differences were found in the levels of the lipid components and glucose in women who were undergoing HRT compared to those without it. Compared to TS-women without (n  =  113), prior GH treatment in 34 TS-women positively influenced the lipid parameters: TC 5.0 ± 1.1 versus 4.6 ± 0.9 mmol/l (p = 0.03), HDL 1.5 ± 0.5 versus 1.4 ± 0.4 mmol/l (p > 0.05), LDL 3.3 ± 0.9 versus 2.9 ± 0.7 mmol/l (p = 0.03), and TG 1.1 ± 0.6 versus 0.8 ± 0.3 g/l (p = 0.009), respectively.
CONCLUSIONS: (1) HRT does not affect lipid metabolism in TS-women. (2) The use of GH in TS-children favorably influences their lipid profile in adulthood.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24400597     DOI: 10.3109/09513590.2013.872236

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

1.  The Cutoff of Gonadotropins for Close Evaluation of Cardiometabolic Risk Factors in Turner Syndrome.

Authors:  Shahin Koohmanaee; Behrang Motamed; Sharareh Ghorbandoust; Hamidreza Badeli; Afagh Hassanzadeh Rad; Setila Dalili; Zohre Darabipour
Journal:  Int J Prev Med       Date:  2022-04-08

2.  Recombinant human growth hormone in treatment of diabetes: report of three cases and review of relative literature.

Authors:  Dandan Wang; Naicheng Zhao; Ziyang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome.

Authors:  Francisco Álvarez-Nava; Marcia Racines; Julia Witt; Jéssica Guarderas; María Estévez; Roberto Lanes
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-09       Impact factor: 3.168

4.  Relationship between Echocardiographic and Magnetic Resonance-Derived Measurements of the Thoracic Aorta in Turner Syndrome Patients.

Authors:  Rūta Krikščiūnienė; Inesa Navickaitė; Eglė Ereminienė; Saulius Lukoševičius; Birutė Žilaitienė; Rasa Verkauskienė
Journal:  Int J Endocrinol       Date:  2019-08-20       Impact factor: 3.257

5.  Increased Insulin Concentrations During Growth Hormone Treatment in Girls With Turner Syndrome Are Ameliorated by Hormone Replacement Therapy.

Authors:  Sabine Elisabeth Segerer; Stephan Georg Segerer; Carl-Joachim Partsch; Wolfgang Becker; Frank Nawroth
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-14       Impact factor: 5.555

6.  The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes.

Authors:  Yael Lebenthal; Sigal Levy; Efrat Sofrin-Drucker; Nessia Nagelberg; Naomi Weintrob; Shlomit Shalitin; Liat de Vries; Ariel Tenenbaum; Moshe Phillip; Liora Lazar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-09       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.